Alberto Zanella

Title: Alberto Zanella: Innovator in Glycolysis-Dependent Pathological Treatments

Introduction

Alberto Zanella is a notable inventor based in Lissone, Italy. He has made significant contributions to the field of medical treatments, particularly in addressing glycolysis-dependent pathological conditions. His innovative approach has the potential to impact the treatment of serious health issues, including cancer.

Latest Patents

Zanella holds a patent for a groundbreaking invention titled "Lactate-protected hypoglycemia to treat glycolysis dependent pathological conditions, in particular cancer." This patent includes a kit that comprises lactic acid, insulin, and glucose, along with optional components such as a glucagon inhibitor, an alpha-beta adrenergic blocker, and an antidiabetic agent. The treatment method involves the intravenous delivery of these components to induce hypoglycemia and hyperlactatemia in humans or animals, targeting conditions like cancer, bacterial infections, or parasite infections.

Career Highlights

Throughout his career, Zanella has focused on developing innovative medical solutions that address complex health challenges. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from glycolysis-dependent conditions.

Collaborations

Zanella collaborates with esteemed colleagues, including Jakob Kampinga and Maarten Willem Nicolaas Nijsten. Their combined expertise enhances the development and application of innovative medical treatments.

Conclusion

Alberto Zanella's contributions to medical innovation, particularly through his patent on lactate-protected hypoglycemia, highlight his commitment to advancing healthcare solutions. His work continues to pave the way for new treatment methodologies in the medical field.